|
Volumn 21, Issue 23, 2003, Pages 267s-269s
|
Therapeutic strategies in gastric cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZACITIDINE;
DNA BINDING PROTEIN;
ENZYME INHIBITOR;
HISTONE DEACETYLASE;
HYDROXAMIC ACID;
METHYLTRANSFERASE;
RUNX3 PROTEIN, HUMAN;
RUNX3 PROTEIN, MOUSE;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR RUNX3;
TRICHOSTATIN A;
TUMOR SUPPRESSOR PROTEIN;
ANIMAL;
ARTICLE;
CELL CULTURE;
DRUG ANTAGONISM;
DRUG EFFECT;
GENE SILENCING;
HUMAN;
METABOLISM;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
PHYSIOLOGY;
STOMACH TUMOR;
ANIMALS;
AZACITIDINE;
CORE BINDING FACTOR ALPHA 3 SUBUNIT;
DNA-BINDING PROTEINS;
ENZYME INHIBITORS;
GENE SILENCING;
HISTONE DEACETYLASES;
HUMANS;
HYDROXAMIC ACIDS;
METHYLTRANSFERASES;
MICE;
MICE, NUDE;
STOMACH NEOPLASMS;
TRANSCRIPTION FACTORS;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 0642368610
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2003.08.536 Document Type: Conference Paper |
Times cited : (10)
|
References (5)
|